Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.43% |
| 2 | Energy | 4.72% |
| 3 | Technology | 4.42% |
| 4 | Financials | 3.4% |
| 5 | Consumer Discretionary | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Fortune Brands Innovations
FBIN
$5.83B
| $556K | ﹤0.01% |
15,927
-69,915
| -81% | -$2.44M |
|
3752
Copart
CPRT
$26.8B
| $553K | ﹤0.01% |
142,776
+112,640
| +374% | +$480K |
|
3753
PUT
Eldorado Gold
EGO
$10.4B
| $553K | ﹤0.01% |
18,440
-1,920
| -9% | -$73.6K |
|
3754
PUT
Oneok
OKE
$58.3B
| $553K | ﹤0.01% |
8,500
-700
| -8% | -$46.9K |
|
3755
PUT
AAR Corp
AIR
$5.96B
| $552K | ﹤0.01% |
23,000
+19,500
| +557% | +$529K |
|
3756
CALL
Civeo
CVEO
$345M
| $552K | ﹤0.01% |
4,183
-650
| -13% | -$196K |
|
3757
CALL
iShares MSCI Australia ETF
EWA
$1.45B
| $552K | ﹤0.01% |
24,000
+7,500
| +45% | +$197K |
|
3758
PUT
Dine Brands
DIN
$462M
| $551K | ﹤0.01% |
6,800
+4,600
| +209% | +$374K |
|
3759
Progress Software
PRGS
$1.79B
| $551K | ﹤0.01% |
23,986
+5,921
| +33% | +$139K |
|
|
ZLTQ
3760
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $551K | ﹤0.01% |
25,038
+24,458
| +4,217% | +$484K |
|
|
MDCO
3761
PUT
DELISTED
Medicines Co
MDCO
| $550K | ﹤0.01% |
25,000
| – | – |
|
3762
Icon
ICLR
$12.9B
| $549K | ﹤0.01% |
9,628
+8,770
| +1,022% | +$451K |
|
3763
PUT
Oil States International
OIS
$536M
| $549K | ﹤0.01% |
9,000
-9,800
| -52% | -$615K |
|
|
RVBD
3764
CALL
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $549K | ﹤0.01% |
30,500
+13,800
| +83% | +$260K |
|
3765
Acadia Healthcare
ACHC
$2.95B
| $548K | ﹤0.01% |
11,439
+1,526
| +15% | +$74.6K |
|
3766
Brink's
BCO
$4.69B
| $548K | ﹤0.01% |
22,874
-4,054
| -15% | -$109K |
|
|
FINL
3767
PUT
DELISTED
Finish Line
FINL
| $548K | ﹤0.01% |
21,900
+11,700
| +115% | +$335K |
|
3768
OneSpan
OSPN
$609M
| $547K | ﹤0.01% |
30,367
+23,727
| +357% | +$347K |
|
3769
PUT
Public Storage
PSA
$60.4B
| $545K | ﹤0.01% |
3,300
-700
| -18% | -$120K |
|
|
CHMT
3770
DELISTED
Chemtura Corporation
CHMT
| $545K | ﹤0.01% |
23,624
-14,844
| -39% | -$368K |
|
3771
CALL
Keurig Dr Pepper
KDP
$40.2B
| $544K | ﹤0.01% |
8,500
-400
| -4% | -$24.4K |
|
|
MFLX
3772
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $541K | ﹤0.01% |
60,067
-983
| -2% | -$10K |
|
3773
PUT
Vulcan Materials
VMC
$36.3B
| $540K | ﹤0.01% |
9,000
+300
| +3% | +$18.9K |
|
|
MCP
3774
DELISTED
MOLYCORP INC COM STK
MCP
| $540K | ﹤0.01% |
540,022
-162,567
| -23% | -$305K |
|
|
OSIR
3775
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $540K | ﹤0.01% |
45,075
+28,748
| +176% | +$410K |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.